GT BIOPHARMA INC - COM NEW (GTBP)

CUSIP: 36254L209

Q4 2022 13F Holders as of 31 Dec 2022

Share change
+3,766,250
SEC-reported price per share
$0.89
Number of holders
30
Value change
+$3,254,489
Number of buys
15
Number of sells
13

Security key

36254L209

Report period

Q4 2022

Institutions

30

Top holders

10

Ownership snapshot

Top reported holders of GTBP - GT BIOPHARMA INC - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
0/15
Latest evidence
30 Sep 2022
13F Highest disclosed value: $1,983,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

VANGUARD GROUP INC has the largest disclosed position value at $1.98M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD GROUP INC's linked filing trail.
Disclosed position value Top 5
VANGUARD GROUP INC $1.98M
BlackRock Finance, Inc. $654K
GEODE CAPITAL MANAGEMENT, LLC $394K
MILLENNIUM MANAGEMENT LLC $271K
STATE STREET CORP $181K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$1,983,000
1,126,941 shares
— 30 Sep 2022
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$654,000
371,778 shares
— 30 Sep 2022
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$394,000
223,908 shares
— 30 Sep 2022
MILLENNIUM MANAGEMENT LLC
13F
Company
13F
—
denominator unverified
$271,000
153,979 shares
— 30 Sep 2022
STATE STREET CORP
13F
Company
13F
—
denominator unverified
$181,000
102,776 shares
— 30 Sep 2022
Bank of New York Mellon Corp
13F
Company
13F
—
denominator unverified
$167,000
95,239 shares
— 30 Sep 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
30
Shares
6,342,497
Rows available
30
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders
29
Q4 2022 holders
30
Holder diff
1
Investor Q3 2022 Shares Q4 2022 Shares Share Diff Share Chg % Q3 2022 value Q4 2022 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .